跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 144 条关于
“rCDI”
全部
144
临床试验
104
药物
20
机构
1
资讯
19
去年
VE303 Shows Promise in Preventing Recurrent Clostridioides difficile Infection
去年
RBX2660 Receives FDA Breakthrough Therapy Designation for Recurrent C. diff Infection
去年
Fecal Microbiota Therapy Shows 95% Success Rate in Preventing Recurrent C. difficile Infection
去年
Genetic Analysis Launches GA-map MHI GutHealth Diagnostic Kit for Recurrent C. difficile Infection
去年
Advancements in Clostridioides difficile Treatment and Prevention Highlighted in 2024
去年
Recursion Doses First Patient in Phase 2 Trial of REC-3964 for Recurrent C. difficile Infection
3个月前
Nestlé and IdB Holding Partner to Bring VOWST Live Biotherapeutic to European Markets
去年
Real-World Data Reinforces Efficacy of Live-jslm (Rebyota) for Recurrent C. difficile Infection
18天前
RedHill Acquires Commercialization Rights to Ferring's Rebyota and Clenpiq in Transformational GI Repositioning
去年
Phase 3b Trial Shows Colonoscopic Administration of Rebyota Effective for Preventing Recurrent C. difficile Infection
第 1 页,共 2 页
上一页
下一页